TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
D.S. Pharma Consulting AB
Closing information (x1000 NOK)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
2,087
|
1,921 | |
| Financial expenses |
8
|
0 | |
| Earnings before taxes |
132
|
19 | |
| EBITDA |
140
|
24 | |
| Total assets |
602
|
585 | |
| Current assets |
602
|
585 | |
| Current liabilities |
283
|
281 | |
| Equity capital |
199
|
304 | |
| - share capital |
98
|
92 | |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
33.1%
|
52.0% | |
| Turnover per employee |
1,044
|
960 | |
| Profit as a percentage of turnover |
6.3%
|
1.0% | |
| Return on assets (ROA) |
23.3%
|
3.2% | |
| Current ratio |
212.7%
|
208.2% | |
| Return on equity (ROE) |
66.3%
|
6.2% | |
| Change turnover |
51
|
287 | |
| Change turnover % |
6%
|
2%
|
18% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.